The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 18-20 September 2024
The following summarizes some of the highlights from Day 3 of ECTRIMS 2024.
Neurology
ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024
September 19, 2024The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 18-20 September 2024
The following summarizes some of the highlights from Day 2 of ECTRIMS 2024.
ECTRIMS 2024 slide resource
September 18, 2024The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 18-20 September 2024
Please note that the NeuroSens ECTRIMS 2024 Highlights slide resource, developed in collaboration with Dr. Daniel Selchen, BARLO MS Centre, Toronto, will be available as of October 10th, on request only. Make your request now by completing the online form. Industry members can also use this form to request to sponsor a NeuroSens post-ECTRIMS event (in-person or virtual). For more information, contact us at info@neuro-sens.com. Read More
ECTRIMS 2024 HIGHLIGHTS – WEDNESDAY, SEPTEMBER 18, 2024
September 18, 2024The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 18-20 September 2024
The following summarizes some of the highlights from Day 1 of ECTRIMS 2024.
Meta-analysis of CBD meta-analyses reports efficacy in younger patients with seizure disorders
August 26, 2024A meta-analysis of 13 meta-analyses reports that cannabidiol (CBD) is effective for children and adolescents with seizures related to Lennox–Gastaut syndrome (LGS), Dravet syndrome (DS) and tuberous sclerosis complex (TSC) (Borowicz-Reutt et al. Molecules 2024;29:1981). Read More